• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
RAC

RACURA ONCOLOGY LTD - Charts / Financials

0.95% ! $2.12
Market Cap $410.6M  !
Healthcare Biotechnology
Add to My Watchlist

Corporate Spotlight


View the full Corporate Spotlight arrow Created with Sketch.

refresh Created with Sketch. REFRESH
Last update - 16.19pm 21/08/2026 (20 minute delay) ?
Day
Open $2.10   Day High $2.16   Day Low $2.03
Daily Volume 65569
Bids   Sellers
Number Price Volume   Number Price Volume
0 $2.06 5000   0 $2.12 1888

Directors & Senior Management

Dr. Borje S. Andersson Chairman of Clinical Advisory Board
Mr. Brendan Brown Chief Financial Officer
Dr. Daniel Douglas Von Hoff Clinical Advisory Board
Dr. Daniel Tillett CEO, MD & Director
Dr. Douglas Smith Member of Scientific Advisory Board
Associate Prof. Erin Howden Member of Scientific Advisory Board
Dr. Jaap-Jan Boelens Member of Clinical Advisory Board
Dr. James Breitenbucher Member of Scientific Advisory Board
Prof. Jianjun Chen Member of Scientific Advisory Board
Dr. Jose L. Iglesias Chief Medical Officer
Dr. Laurence H. Hurley Member of Scientific Advisory Board
Dr. Martin S. Tallman Member of Scientific Advisory Board
Dr. Megan Baldwin Independent Non-Executive Director
Mr. Peter Gordon Webse Company Secretary
Dr. Peter Michael Smith Executive Chairman
Mr. Peter Molloy Chief Executive Officer
Dr. Roland Walter Member of Scientific Advisory Board
Dr. Serge Scrofani Independent Non-Executive Director
Dr. Sophia Moscovis Vice President of Operations & Strategy

Data source: ADVFN

Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
Start T rading
Last
$2.12 		Change
0.020(0.95%) 		Mkt cap ! $410.6M
Open High Low Volume
$2.10 $2.16 $2.03 65.56K

Buyers (Bids)

Vol. Price($)
5000 $2.06
 

Sellers (Offers)

Price($) Vol.
$2.12 1888
Last trade - 16.19pm 21/08/2026 (20 minute delay) ?

Top Stories

Guzman y Gomez posts record earnings as Australia expansion accelerates

Guzman y Gomez reports strong FY26 earnings growth, exits the US and plans 35 new Australian restaurants in FY27.
Tungsten has soared +700% YTD, the US is curbing its exports, and this ASX stock is targeting production in Q1CY27 Right now, the US-Israel-Iranian war in the Middle East and the ongoing war in Ukraine are both increasing global demand for a critical mineral vital for national security and defence: tungsten. While not the whole story of its appeal, tungsten has the highest melting point of any metal and is hi...
Noble Helium expanding portfolio with move to acquire Earth Source Hydrogen Noble Helium has entered into a binding agreement to acquire 100% of the issued share capital of Earth Source Hydrogen.
Dale Gillham: Where is Corporate Australia Placing its Bets in 2027? This reporting season could make 2027 far more interesting than investors expect.We’re still talking about inflation, weak growth, geopolitical risk and whether markets have run too far. Yet beneath those concerns, some of Australia’s biggest companies appear to be...
HotCopper Highlights: Zip dominates investor attention as Telix, Liontown and American Tungsten trend Zip Co and Telix were among HotCopper’s most watched stocks this week, while Liontown, AT4 and BrainChip drove investor discussion.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.